DSM Biologics and Australian Plant Included in Patheon Merger

As reported by biopharma-reporter.com, Royal DSM has confirmed that its biologics manufacturing operations and new Australian facility will be part of the business merged with Patheon in its agreement with JLL.

Read the article here